- Home
- JOF vs XOMA Comparison
JOF vs XOMA Comparison
Compare JOF & XOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JOF
- XOMA
- Stock Information
- Founded
- JOF 1990
- XOMA 1981
- Country
- JOF Japan
- XOMA United States
- Employees
- JOF N/A
- XOMA N/A
- Industry
- JOF Trusts Except Educational Religious and Charitable
- XOMA Biotechnology: Pharmaceutical Preparations
- Sector
- JOF Finance
- XOMA Health Care
- Exchange
- JOF Nasdaq
- XOMA Nasdaq
- Market Cap
- JOF 254.4M
- XOMA 300.5M
- IPO Year
- JOF N/A
- XOMA N/A
- Fundamental
- Price
- JOF $9.43
- XOMA $27.76
- Analyst Decision
- JOF
- XOMA Strong Buy
- Analyst Count
- JOF 0
- XOMA 2
- Target Price
- JOF N/A
- XOMA $69.50
- AVG Volume (30 Days)
- JOF 43.9K
- XOMA 55.2K
- Earning Date
- JOF 01-01-0001
- XOMA 08-12-2025
- Dividend Yield
- JOF 3.33%
- XOMA N/A
- EPS Growth
- JOF N/A
- XOMA N/A
- EPS
- JOF N/A
- XOMA N/A
- Revenue
- JOF N/A
- XOMA $42,909,000.00
- Revenue This Year
- JOF N/A
- XOMA $70.91
- Revenue Next Year
- JOF N/A
- XOMA $14.00
- P/E Ratio
- JOF N/A
- XOMA N/A
- Revenue Growth
- JOF N/A
- XOMA 638.41
- 52 Week Low
- JOF $6.64
- XOMA $18.35
- 52 Week High
- JOF $8.04
- XOMA $35.00
- Technical
- Relative Strength Index (RSI)
- JOF 53.60
- XOMA 66.21
- Support Level
- JOF $9.36
- XOMA $23.47
- Resistance Level
- JOF $9.77
- XOMA $24.65
- Average True Range (ATR)
- JOF 0.11
- XOMA 1.28
- MACD
- JOF -0.05
- XOMA 0.16
- Stochastic Oscillator
- JOF 19.51
- XOMA 88.37
About JOF Japan Smaller Capitalization Fund Inc
Japan Smaller Capitalization Fund Inc is a closed-end management investment company. Its investment objective is to seek long-term capital appreciation through investments in smaller capitalization Japanese equity securities. Its portfolio of investments consists of different sectors such as banks, chemicals, construction, electric appliances, financing business, food, Information and Communication, Utilities, Real Estate, and others.
About XOMA XOMA Corporation
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.